Fang, J.Y., Wang, P.W., Huang, C.H., Chen, M.H., Wu, Y.R., Pan, T.L. (2016) Skin aging caused by intrinsic or extrinsic processes characterized with functional proteomics. Proteomics, 16, 2718-2731.
Chen, Y.L., Hwang, T.L., Yu, H.P., Fang, J.Y., Chong, K.Y., Chang, Y.W., Chen, C.Y., Yang, H.W., Chang, W.Y., Hsieh, P.W. (2016) Ilex kaushue and its bioactive component 3,5-dicaffeoylquinic acid protected mice from lipopolysaccharide-induced acute lung injury. Sci. Rep., 6, 34243.
Yu, I.C., Tsai, Y.F., Fang, J.T., Yeh, M.M., Fang, J.Y., Liu, C.Y. (2016) Effects of mouthwash interventions on xerostomia and unstimulated whole saliva flow rate among hemodialysis patients: A randomized controlled study. Int. J. Nurs. Stud., 63, 9-17.
Aljuffali, I.A., Lin, C.F., Chen, C.H., Fang, J.Y.* (2016) The codrug approach for facilitating drug delivery and bioactivity. Expert Opin. Drug Deliv., 13, 1311-1325.
Aljuffali, I.A., Fang, C.L., Chen, C.H., Fang, J.Y.* (2016) Nanomedicine as a strategy for natural compound delivery to prevent and treat cancers. Curr. Pharm. Design, 22, 4219-4231.
Lin, Z.C., Lee, C.W., Tsai, M.H., Ko, H.H., Fang, J.Y., Chiang, Y.C., Liang, C.J., Hsu, L.F., Hu, S.C.S., Yen, F.L. (2016) Eupafolin nanoparticles protect HaCaT keratinocytes from particulate matter-induced inflammation and oxidative stress. Int. J. Nanomed., 11, 3907-3926.
Lin, C.F., Hung, C.F., Aljuffali, I.A., Huang, Y.L., Liao, W.C., Fang, J.Y.* (2016) Methylation and esterification of magnolol for ameliorating cutaneous targeting and therapeutic index by topical application. Pharm. Res., 33, 2152-2167.
Lee, W.R., Shen, S.C., Aljuffali, I.A., Lin, Y.K., Huang, C.W., Fang, J.Y.* (2016) Non-ablative fractional laser assists cutaneous delivery of small- and macro-molecules with minimal bacterial infection risk. Eur. J. Pharm. Sci., 92, 1-10.
Lee, C.W., Lin, Z.C., Hu, S.C.S., Chiang, Y.C., Hsu, L.F., Lin, Y.C., Lee, I.T., Tsai, M.H., Fang, J.Y.* (2016) Urban particulate matter down-regulates filaggrin via COX2 expression/PGE2 production leading to skin barrier dysfunction. Sci. Rep., 6, 27995.
Liu, K.S., Chen, Y.W., Aljuffali, I.A., Chang, C.W., Wang, J.J., Fang, J.Y.* (2016) Topically applied mesoridazine exhibits the strongest cutaneous analgesia and minimized skin disruption among tricyclic antidepressants: the skin absorption assessment. Eur. J. Pharm. Biopharm., 105, 59-68.
Lee, C.W., Lin, Z.C., Hsu, L.F., Fang, J.Y., Chiang, Y.C., Tsai, M.H., Lee, M.H., Li, S.Y., Hu, S.C., Lee, I.T., Yen, F.L. (2016) Eupafolin ameliorate COX-2 expression and PGE2 production in particulate pollutants-exposed human keratinocytes through ROS/MAPKs pathways. J. Ethnopharmacol., 189, 300-309.
Lin, C.H., Chang, S.H., Fang, J.Y.* (2016) Recent advances using phosphodiesterase 4 (PDE4) inhibitors to treat inflammatory disorders: animal and clinical studies. Curr. Drug Ther., 11, 21-40.
Yang, S.C., Aljuffali, I.A., Sung, C.T., Lin, C.F., Fang, J.Y.* (2016) Antimicrobial activity of topically-applied soyaethyl morpholinium ethosulfate micelles against Staphylococcus species. Nanomedicine, 11, 657-671.
Pan, T.L., Wang, P.W., Hung, C.F., Aljuffali, I.A., Dai, Y.S., Fang, J.Y.* (2016) The impact of retinol loading and surface charge on the hepatic delivery of lipid nanoparticles. Colloids Surf. B, 141, 584-594.
Aljuffali, I.A., Lin, Y.K., Fang, J.Y.* (2016) Noninvasive approach for enhancing small interfering RNA delivery percutaneously. Expert Opin. Drug Deliv., 13, 265-280.
Chuang, S.Y., Lin, C.F., Aljuffali, I.A., Fang, J.Y.* (2016) Specific targeting of engineered nanoparticles to activated macrophages. Curr. Nanosci., 12, 63-69.
Fang, Y.P., Yang, S.H., Lee, C.H., Aljuffali, I.A., Kao, H.C., Fang, J.Y.* (2016) What is the discrepancy between drug permeation into/across intact and diseased skins? Atopic dermatitis as a model. Int. J. Pharm., 497, 277-286.